Nanoparticle vaccine candidate for COVID-19 shows promise in preclinical studies

Researchers from Chungbuk National University (Cheongju, Republic of Korea) and the Cleveland Clinic’s Global Center for Human Health & Pathogen Research (OH, USA) have developed a potential vaccine candidate for COVID-19 using nanotechnology, with studies suggesting the vaccine candidate may be thermostable. The research was published in mBio, with results showing the vaccine produced potent neutralizing antibodies in preclinical models. A current challenge faced by many vaccines is the requirement for strict temperature control until the vaccine is administered, therefore a thermostable vaccine would avoid certain logistical challenges during transport and storage. Jae Jung (Cleveland Clinic), Director of the Global...